# A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects

> **NCT04880642** · PHASE3 · COMPLETED · sponsor: **Vicore Pharma AB** · enrollment: 272 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** C21
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04880642
- **Lead sponsor:** Vicore Pharma AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-16
- **Primary completion:** 2022-04-25
- **Final completion:** 2022-04-25
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2023-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04880642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04880642, "A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04880642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*